Indian Stocks
All posts from Indian Stocks
Indian Stocks in Indian Stocks,

India: benchmarks retreat on profit taking

Indian stock indices ended marginally in the red on Friday, July 14 as investors took profits after gains in the last four sessions in a row. In addition, market participants priced in today’s quarterly earnings, including those from Infosys and Tata Consultancy Services, while awaiting a number of key macro data and bank earnings stateside. 

Recapping the benchmarks, the Nifty 50 ticked down 0.05% to 9,886.35, and the BSE Sensex eased 0.05%, settling at 32,020.75. By 10:45 GMT, USD/INR traded up 0.05% to 64.468, and EUR/INR firmed 0.16% to 73.5890. The 10-year Indian government bond yield stood at 6.471%. 

India’s largest software exporter Tata Consultancy Services plunged 2% after posting downbeat quarterly earnings. 

 Infosys, another software exporter, shed 0.51%, although it picked up in early trading on the back of slightly better-than-expected fiscal 1Q profit. 

Pharmaceutical player Biocon was well bid, spiking 8.88% on reports that the Oncologic Drugs Advisory Committee recommended the US FDA approve breast cancer drug Trastuzumab, which the company developed jointly with Mylan. 

The daily chart shows that the BSE Sensex is trading within a rising wedge slightly below the all-time and intraday highs, while the Slow Stochastic Oscillator is hovering near overbought territory. Consequently, the benchmark holds limited upside potential in the short term.